These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9815238)

  • 1. Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans.
    Mann DL; Garner RP; Dayhoff DE; Cao K; Fernández-Viña MA; Davis C; Aronson N; Ruiz N; Birx DL; Michael NL
    J Infect Dis; 1998 Dec; 178(6):1799-802. PubMed ID: 9815238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
    Gao X; Nelson GW; Karacki P; Martin MP; Phair J; Kaslow R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; O'Brien SJ; Carrington M
    N Engl J Med; 2001 May; 344(22):1668-75. PubMed ID: 11386265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.
    Gaudieri S; DeSantis D; McKinnon E; Moore C; Nolan D; Witt CS; Mallal SA; Christiansen FT
    Genes Immun; 2005 Dec; 6(8):683-90. PubMed ID: 16121209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans.
    An P; Martin MP; Nelson GW; Carrington M; Smith MW; Gong K; Vlahov D; O'Brien SJ; Winkler CA
    AIDS; 2000 Sep; 14(14):2117-22. PubMed ID: 11061652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQB1 markers associated with human immunodeficiency virus type I disease progression.
    Achord AP; Lewis RE; Brackin MN; Cruse JM
    Pathobiology; 1997; 65(4):210-5. PubMed ID: 9396045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
    Catano G; Kulkarni H; He W; Marconi VC; Agan BK; Landrum M; Anderson S; Delmar J; Telles V; Song L; Castiblanco J; Clark RA; Dolan MJ; Ahuja SK
    PLoS One; 2008; 3(11):e3636. PubMed ID: 18982067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 disease association with HLA-DQ antigens in African Americans and Caucasians.
    Achord AP; Lewis RE; Brackin MN; Henderson H; Cruse JM
    Pathobiology; 1996; 64(4):204-8. PubMed ID: 9031330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method.
    Winchester R; Chen Y; Rose S; Selby J; Borkowsky W
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12374-8. PubMed ID: 8618904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.
    van Manen D; Kootstra NA; Boeser-Nunnink B; Handulle MA; van't Wout AB; Schuitemaker H
    AIDS; 2009 Jan; 23(1):19-28. PubMed ID: 19050382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1.
    Roe DL; Lewis RE; Cruse JM
    Exp Mol Pathol; 2000 Feb; 68(1):21-8. PubMed ID: 10640451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
    Kaslow RA; Carrington M; Apple R; Park L; Muñoz A; Saah AJ; Goedert JJ; Winkler C; O'Brien SJ; Rinaldo C; Detels R; Blattner W; Phair J; Erlich H; Mann DL
    Nat Med; 1996 Apr; 2(4):405-11. PubMed ID: 8597949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Weng S; Carrington M; Mellors J; Rinaldo CR; Mann D; Apple R; Phair JP; Detels R; O'Brien S; Enger C; Johnson P; Kaslow RA
    AIDS; 1998 Nov; 12(16):2107-13. PubMed ID: 9833851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
    Gonzalez E; Bamshad M; Sato N; Mummidi S; Dhanda R; Catano G; Cabrera S; McBride M; Cao XH; Merrill G; O'Connell P; Bowden DW; Freedman BI; Anderson SA; Walter EA; Evans JS; Stephan KT; Clark RA; Tyagi S; Ahuja SS; Dolan MJ; Ahuja SK
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12004-9. PubMed ID: 10518566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.
    Vlahov D; Graham N; Hoover D; Flynn C; Bartlett JG; Margolick JB; Lyles CM; Nelson KE; Smith D; Holmberg S; Farzadegan H
    JAMA; 1998 Jan; 279(1):35-40. PubMed ID: 9424041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Smith MW; Dean M; Carrington M; Winkler C; Huttley GA; Lomb DA; Goedert JJ; O'Brien TR; Jacobson LP; Kaslow R; Buchbinder S; Vittinghoff E; Vlahov D; Hoots K; Hilgartner MW; O'Brien SJ
    Science; 1997 Aug; 277(5328):959-65. PubMed ID: 9252328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.
    Tang J; Shelton B; Makhatadze NJ; Zhang Y; Schaen M; Louie LG; Goedert JJ; Seaberg EC; Margolick JB; Mellors J; Kaslow RA
    J Virol; 2002 Jan; 76(2):662-72. PubMed ID: 11752157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
    Martin MP; Gao X; Lee JH; Nelson GW; Detels R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; Trowsdale J; Wilson M; O'Brien SJ; Carrington M
    Nat Genet; 2002 Aug; 31(4):429-34. PubMed ID: 12134147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies.
    Kroner BL; Goedert JJ; Blattner WA; Wilson SE; Carrington MN; Mann DL
    AIDS; 1995 Mar; 9(3):275-80. PubMed ID: 7755916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA disease association and protection in HIV infection among African Americans and Caucasians.
    Cruse JM; Brackin MN; Lewis RE; Meeks W; Nolan R; Brackin B
    Pathobiology; 1991; 59(5):324-8. PubMed ID: 1910527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.